HSPD1 and lip and oral cavity carcinoma: Similarly, TCGA data analysis showed that oral cancer patients with co-expression level of high HSPD1/low E-cadherin also had poor OS (log rank p = 0.023, Fig. 5G; AHR = 1.86, 95% CI = 1.15–3.01, p = 0.012, Supplementary Table S3).